Impact biomedical announces new bioplastics test results

Rochester, n.y., jan. 11, 2022 (globe newswire) -- impact biomedical, inc., a wholly owned subsidiary of dss, inc. (nyse american: dss) along with its scientific research partner global research and discovery group sciences, (grdg) announced today a project that is designed to take plastics in a whole new direction with the development of what we call bio-plastics. bio-plastics under development are designed to make everyday objects resistant to viruses, and also gentler to the planet.
DSS Ratings Summary
DSS Quant Ranking